A Foreword from the Editor

© 2018 by the Author(s). Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/ )

Download PDF

Cite

XML

HTML

Abstract

Welcome to the 3rd issue of the Journal of Medicines Development Sciences. Like previous issues it contains articles covering the entire process of drug development from target identification to drug registration.

References

1. Boeynaems J-M, Communi D and Robaye B, 2012, Overview of the pharmacology and physiological roles of P2Y receptors. Wiley Interdisciplinary Reviews (WIREs): Membrane Transport and Signaling, vol.1(5): 581–588.
http://dx.doi.org/10.1002/WMTS.44
2. Barbaras R, 2015, HDL therapies — past, present and future. Journal of Medicines Development Sciences, vol.1(2): 2–11. http://dx.doi.org/10.18063/JMDS.2015.02.005
3. Silva H, Koski G, Whalen M, et al. 2015, A systems approach to enhance clinical research and medicines development. Journal of Medicines Development Sciences, vol.1(1): 59–67.http://dx.doi.org/10.18063/JMDS.2015.01.004
4. Rosenkranz B, Reid M and Allen E, 2015, Medicines development and regulation in Africa. Journal of Medicines Development Sciences, vol.1(2): 33–36. http://dx.doi.org/10.18063/JMDS.2015.02.006
5. Chee D, Park M S and Sohn J-H, 2015, New initiatives for transforming clinical research in Korea. Journal of Medicines Development Sciences, vol.1(2): 27–32. http://dx.doi.org/10.18063/JMDS.2015.02.003

Previous article in this issue

Next article in this issue